Matsayi na Kulawa (PoC) Kasuwancin Ciwon Magunguna na Kalubale na Gabatarwa da Hasashen Girman Masana'antu ta hanyar 2020-2026

Selbyville, Delaware, Amurka, Oktoba 23 2020 (Wiredrelease) Hasashen Kasuwa na Duniya, Inc -: Mahimmancin kula da ƙwayoyin cuta (POC) Kasuwancin bincike yana shirye don haɓakar haɓakawa a bayan haɓakar cututtukan cututtukan da ke yaduwa a duniya. A cikin 'yan shekarun nan, kamuwa da cututtuka a duniya kamar mura, tarin fuka, HIV, hepatitis C, da ƙwayoyin cuta na numfashi suna haɓaka cikin sauri. Kamar yadda alkalumman CDC (Cibiyoyin Kula da Cututtuka da Cututtuka), mura, kwayar cutar numfashi ta yanayi, ita ce ke da alhakin kusan ziyarar likita miliyan 14 zuwa miliyan 21 a cikin Amurka ta Amurka kadai tun daga 1 ga Oktoba, 2019.

Ko da yake mura yana da ingantaccen maganin rigakafi, yana da mahimmanci ga marasa lafiya su sami magungunan rigakafin cikin sa'o'i 48 na bayyanar cututtuka. Wannan ya haifar da karuwa a cikin buƙatun farkon gano cututtukan ƙwayoyin cuta da fassarar sakamako mai sauri, ƙirƙirar damar haɓaka haɓaka mai fa'ida don kasuwar gano ƙwayoyin cuta (POC).

Nemi samfurin kwafin wannan rahoton @ https://www.gminsights.com/request-sample/detail/2210

Wani binciken da aka gudanar a GMI kuma ya ba da shawarar cewa ana sa ran kasuwar gano ƙwayoyin cuta (POC) za ta zarce dala biliyan 2.8 nan da 2026.

Ba abu ne da ba za a iya musantawa ba cewa binciken kwayoyin POC yana taka muhimmiyar rawa wajen gano cututtuka musamman. A haƙiƙa, ɓangaren aikace-aikacen cututtukan cututtukan ya kai sama da dalar Amurka miliyan 780 a cikin 2019. Binciken ƙwayoyin cuta yana da babban yanki na cututtukan cututtukan da ke da alaƙa da aikace-aikacen sabili da fasalinsa da yawa kamar mafi ƙarancin lokacin juyawa da haɓaka ƙayyadaddun ƙayyadaddun abubuwan gano ƙwayoyin cuta. 

Bugu da ƙari, ƙididdigar ƙwayoyin cuta sun kuma inganta ganewar cututtukan cututtuka na ciki, ciki har da Clostridium difficile da kwayoyin da ba su da al'ada ta amfani da hanyoyin al'ada na al'ada irin su gondii, Bartonella, Toxoplasma, da Leishmania. A kan wannan bayanin, ana tsammanin kasuwar binciken kwayar cutar ta Point of Care (POC) za ta yi rikodin manyan kudaden shiga daga sashin cututtukan. 

Kasuwancin ƙwayoyin cuta na POC yana haɓaka da gaske a cikin sashin asibitoci a cikin 'yan shekarun nan. Dangane da kimantawa, ana tsammanin sashin asibiti zai yi rikodin 8% CAGR ta 2020-2026. Ana iya danganta wannan haɓakar ɓangarori zuwa haɓaka haɓakar fasahar zamani kamar haɓaka isothermal, PCR, da jeri a cikin saitunan asibiti don mafi girma da saurin ganewa. Haka kuma, fa'idodi da yawa kamar ingantattun zaɓuɓɓukan magani masu rahusa za su ƙara ƙarfafa asibitoci don zaɓar hanyoyin gano ƙwayoyin ƙwayoyin cuta a cikin lokacin hasashen.

A kan yankin yanki, APAC ana tsammanin zai ba da damar haɓaka mai fa'ida ga ci gaban kasuwar ƙwayoyin cuta ta POC. Ana iya danganta wannan ci gaban ga kyawawan tsare-tsare da gwamnatoci ke girka don maganin farko da kuma gano cututtukan ƙwayoyin cuta.

Da yake bayar da misali don haskaka irin wannan, Ma'aikatar Lafiya, Kwadago, da Jin Dadin Jama'a ta Japan kwanan nan ta gabatar da shirin JANIS (Japan Nosocomial Infections Surveillance) don samar da bayanai kan yawaitar ƙwayoyin cuta da cututtuka a cikin wuraren kiwon lafiya. Irin waɗannan yunƙurin na gwamnatoci suna iya haɓaka hasashen kasuwancin POC na ƙwayoyin cuta a cikin lokacin hasashen.

Neman keɓancewa @ https://www.gminsights.com/roc/2210

Yayin da yake magana game da filin wasan gasa, yana da mahimmanci a ambaci cewa POC kasuwar binciken kwayoyin halitta tana da ƙaƙƙarfan kasancewar ingantattun 'yan wasa. Waɗannan kamfanoni suna yin amfani da dabarun haɓakar ƙwayoyin cuta da ƙwayoyin cuta kamar haɗe-haɗe, saye, ƙaddamar da samfur don samun babban rabon kasuwa.

Da yake ba da misali don tabbatar da jumlar da aka ambata, a cikin Maris 2020, Siemens Healthcare ta karɓi izinin US FDA (Hukumar Abinci da Magunguna) don RapidPoint 500e Mai Binciken Gas na Jini. Kamfanin ya ƙaddamar da wannan hanyar gwaji don sa ido kan marasa lafiya, gami da COVID-19, a cikin saitunan kulawa. Musamman ma, wasu fitattun 'yan wasan kasuwanci da ke aiki a cikin masana'antar bincikar ƙwayoyin cuta sun haɗa da Sysmex, Danaher, Vircell, Abbott Laboratories, Bio-Rad Laboratories, da sauransu.  

Babin Sashi na Teburin entunshi 

Babi na 4. Batun Kula da Kasuwar Binciken Kwayoyin Halitta, Ta Fasaha

4.1. Yanayin maɓallin keɓaɓɓu

4.2. PCR

4.2.1. Kasuwancin PCR, ta yanki, 2015 - 2026, (USD Million)

4.3. A cikin yanayi hybridization

4.3.1. A cikin situ hybridization kasuwa, ta yanki, 2015 - 2026, (USD Million)

4.4. Jeri

4.4.1. Kasuwar jeri, ta yanki, 2015 - 2026, (USD Million)

4.5. Isothermal ƙarawa

4.5.1. Kasuwancin haɓakawa na Isothermal, ta yanki, 2015 - 2026, (USD Million)

4.6. Sauran

4.6.1. Wasu kasuwa, ta yanki, 2015 - 2026, (USD Million)

Babi na 5. Batun Kula da Kasuwar Binciken Kwayoyin Halitta, Ta Aikace-aikace

5.1. Yanayin maɓallin keɓaɓɓu

5.2. Cutar cututtuka

5.2.1. Kasuwar cututtuka ta yanki, 2015 - 2026 (US miliyan)

5.2.2. mura

5.2.2.1. Kasuwar mura, ta yanki, 2015 - 2026 (US Million)

5.2.3. Cutar tarin fuka

5.2.3.1. Kasuwar tarin fuka, ta yanki, 2015 - 2026 (US miliyan)

5.2.4. HIV

5.2.4.1. Kasuwar HIV, ta yanki, 2015 - 2026 (US Million)

5.2.5. Gonorrhea

5.2.5.1. Kasuwar gonorrhea, ta yanki, 2015 - 2026 (USD Million)

5.2.6. Chlamydia

5.2.6.1. Kasuwar Chlamydia, ta yanki, 2015 - 2026 (USD Million)

5.2.7. Hepatitis C

5.2.7.1. Kasuwar Hepatitis C, ta yanki, 2015 - 2026 (US miliyan)

5.2.8. Hepatitis B

5.2.8.1. Kasuwar Hepatitis B, ta yanki, 2015 - 2026 (US Million)

5.2.9. Sauran

5.2.9.1. Wasu kasuwa, ta yanki, 2015 - 2026 (US Million)

5.3. Ciwon daji

5.3.1. Kasuwancin Oncology, ta yanki, 2015 - 2026 (US Million)

5.4. Cututtukan Jini

5.4.1. Kasuwancin Hematology, ta yanki, 2015 - 2026 (US Million)

5.5. Sauran

5.5.1. Wasu kasuwa, ta yanki, 2015 - 2026 (US Million) 

Binciko cikakken abin da ke ciki (TOC) na wannan rahoton @ https://www.gminsights.com/toc/detail/point-of-care-poc-molecular-diagnostics-market

An wallafa wannan abun ta kamfanin Global Market Insights, kamfanin Inc. Ma'aikatar Labaran WiredRelease ba ta shiga cikin ƙirƙirar wannan ƙunshiyar ba. Don binciken sabis na sakin latsawa, da fatan za a same mu a [email kariya].